BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6993080)

  • 1. Circulating immune complexes in old people and in diabetics: correlation with autoantibodies.
    Delespesse G; Gausset P; Sarfati M; Dubi-Rucquoy M; Debisschop MJ; van Haelst L
    Clin Exp Immunol; 1980 Apr; 40(1):96-102. PubMed ID: 6993080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes in type I diabetics with persistent islet cell antibodies.
    Irvine WJ; Di Mario U; Guy K; Borsey DQ
    J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet cell antibodies and diabetes in Nigerians.
    Oli JM; Bottazzo GF; Doniach D
    Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes in newly diagnosed insulin-dependent (type I) diabetics.
    Irvine WJ; Di Mario U; Guy K; Feek CM; Gray RS; Duncan LJ
    J Clin Lab Immunol; 1978 Nov; 1(3):183-6. PubMed ID: 387959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in various thyroid diseases.
    Brohee D; Delespesse G; Debisschop MJ; Bonnyns M
    Clin Exp Immunol; 1979 Jun; 36(3):379-83. PubMed ID: 487642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes and peripheral B lymphocytes in non insulin dependent diabetic patients.
    Barañao RI; Tesone PA; Chasseing NA; Mendelson M; Rumi LS
    Acta Physiol Lat Am; 1983; 33(2):111-6. PubMed ID: 6230879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
    Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
    J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatment.
    Di Mario U; Irvine WJ; Guy K; Borsey DQ; Iavicoli M; Ventriglia L
    J Clin Lab Immunol; 1983 May; 11(1):17-20. PubMed ID: 6348294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute viral hepatitis in the Florence area: II. Immunologic study].
    Passaleva A; Massai G; Leoncini F; Dionisio D; Paci P; Ricci M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):224-37. PubMed ID: 6639776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Islet-cell antibodies and organ-specific antibodies in diabetic children and adolescents. Relationship with age, age at onset, duration of diabetes, residual insulin secretion and retinopathy (author's transl)].
    Dorchy H; Lemiere B; Toussaint D; Gausset P
    Nouv Presse Med; 1981 Sep; 10(34):2795-8. PubMed ID: 7031599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Auto-immunity and insulin-dependent diabetes].
    Vialettes B; Beaume D; Vague P
    Diabete Metab; 1982 Dec; 8(4):349-55. PubMed ID: 6761189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Islet cell antibodies in diabetic patients with other autoimmune diseases (author's transl)].
    Pujol-Borrell R; Richart C; Marti S; Gomez JM
    Nouv Presse Med; 1981 Sep; 10(34):2791-3. PubMed ID: 7031598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
    Barañao RI; Tesone PA; Garberi JC; Mendelson MJ; Rumi LS
    Acta Physiol Pharmacol Latinoam; 1985; 35(2):145-51. PubMed ID: 2938403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immunity in type 1 diabetes mellitus: a prospective study.
    Borsey DQ; Di Mario U; Irvine WJ; Gray RS; Guy K; Weston J; Peutherer J; Duncan LJ
    J Clin Lab Immunol; 1983 May; 11(1):9-15. PubMed ID: 6876143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in patients with diabetes mellitus.
    Abrass CK; Heber D; Lieberman J
    Clin Exp Immunol; 1983 Apr; 52(1):164-72. PubMed ID: 6305541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
    Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
    J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-islet cell antibodies in insulin-dependent diabetics. Preliminary study].
    Colimberti D; Mancino C; Notaro L; Pinzone F; Rinaldi A; Triolo G
    Minerva Med; 1978 Oct; 69(51):3515-8. PubMed ID: 366462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
    Fairchild RS; Kyner JL; Abdou NI
    J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.